Engflag

Indax

Quick links to important sections

Indax

Indax_EN

Method of action: Antihypertensive, Diuretic, Hypotensive, Vasodilator

Treatment option: Hypertension

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Indax

Property Description
Active ingredient Indapamide
Form Tablet, Film-coated tablet
Pharmacological class Diuretic; Antihypertensive Agent
General purpose Management of high blood pressure
Origin Synthetic; Benzamide Sulfonamide Derivative

Indax is a Prescription-only medicine (Rx) used primarily in Antihypertensive therapy for the essential management of high blood pressure. This Monocomponent drug is classified both as an Antihypertensive agent and a Diuretic, and its Active ingredient is the Synthetic compound Indapamide. Indax is prepared as an Oral dosage form, typically a Tablet or Film-coated tablet.

What Type of Medicine is Indax?

Indax is classified pharmacologically as a Thiazide-like diuretic within the broader family of Sulfonamide diuretics. The Active ingredient Indapamide is a Benzamide Sulfonamide Derivative, distinct from classic Thiazide diuretics. This classification is based on its specific chemical structure, with the compound defined by the chemical formula C16H16ClN3O3S. Indapamide is utilized for long-term vascular protection and the management of chronic hypertensive conditions, serving as a significant component in public health strategies for blood pressure control.

Indax Composition and General Purpose

The purpose of Indax is to reduce and control blood pressure through its Dual-Action mechanism, addressing both fluid volume and blood vessel resistance. Indax utilizes Indapamide to exert a Natriuretic effect by modulating Renal electrolyte transport in the kidney, which leads to Water and Salt Removal. Concurrently, Indapamide provides Vascular Relaxation, helping to widen blood vessels and ease the overall pressure within the circulatory system. Indapamide serves as a primary agent for managing hypertension and stabilizing long-term blood pressure, contributing to the reduction of cardiovascular risk. This comprehensive approach makes the Oral dosage form a reliable tool for long-term high blood pressure management.

Regulatory References

  1. Indapamide in WHO EML

What side effects are possible with Indax?

Possible side effects and safety information

Indax (Indapamide) is associated with adverse reactions officially classified by frequency, with the majority of effects concerning fluid and electrolyte balance. The most frequently documented safety characteristic is the potential for Hypokalaemia (low potassium levels in the blood), which is officially classified as a Very Common or Common event depending on the dose and regulatory label. Other Common reactions include headache, fatigue, dizziness, and specific dermatological hypersensitivity reactions, such as rash and pruritus.

Official Adverse Reaction Groupings

The medicine's safety profile groups adverse effects by physiological system, including Metabolism and Nutrition disorders (e.g., hyponatraemia, hypovolaemia), Nervous System disorders (e.g., vertigo, paraesthesia), and Gastrointestinal disorders (e.g., nausea, vomiting).

Serious Adverse Reactions, while Very Rare, are officially documented and include the potential for life-threatening cardiac arrhythmias, specifically Torsade de pointes, often linked to severe hypokalaemia. Other serious effects include severe cutaneous reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and rare blood disorders such as Agranulocytosis.

Safety Constraints and Special Populations

Official labeling contains specific high-level constraints and monitoring requirements. Indax is contraindicated in patients with pre-existing Severe Renal Failure, Severe Hepatic Impairment, and Refractory Hypokalaemia. The regulatory safety profile notes that the risk of Hypovolaemia and acute electrolyte disturbances is often more pronounced at the initiation of therapy. Furthermore, use in patients with severe hepatic impairment carries a documented risk of precipitating Hepatic Encephalopathy.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Indax overdose is defined by the severe systemic consequences of its exaggerated pharmacological effect, mandating specific emergency responses.

Documented Overdose Manifestations

Overdose presentations are primarily characterized by signs of fluid and electrolyte losses, including pronounced hypotension (low blood pressure), muscular weakness, and gastrointestinal upset such as vomiting. Documented central nervous system effects include drowsiness, confusion, and lethargy. Physiological findings noted in regulatory documents include critical electrolyte imbalances like hypokalaemia (low potassium) and hyponatraemia (low sodium), alongside an exaggerated diuretic effect leading to severe volume depletion.

Required Emergency Actions and Monitoring

In the event of a suspected overdose, seeking immediate medical attention is required. Management is strictly symptomatic and supportive, as the official labeling indicates no specific antidote is known. Regulatory guidance specifies that procedures may involve measures such as gastric lavage and that patients require close monitoring for critical fluid and electrolyte abnormalities in a hospital setting.

Severe Outcomes and Special Risks

Overdose carries the risk of life-threatening hyponatraemia and the precipitation of hepatic encephalopathy or hepatic coma in individuals with pre-existing impaired hepatic function. Additionally, the resulting severe hypokalaemia can increase the risk of serious cardiac arrhythmias. Increased severity and specific risks are noted for elderly patients and those with impaired liver function.

Therapeutic Uses of Indax

What Indax Treats: Main Uses and Benefits

The primary use of Indax is applied across domains where additional symptomatic support is needed to address physical discomfort and symptoms that interfere with daily functioning. The medicine is used to help with symptomatic relief in conditions characterized by periods of heightened symptoms.

The medicine is applied in addressing symptomatic manifestations across conditions presenting with systemic or localized discomfort, such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gouty arthritis, and acute painful shoulder.

Symptomatic Support for Discomfort and Strain

Indax is applied in addressing certain distressing symptoms that may become intense or disruptive, helping to manage symptoms related to physical discomfort and functional strain. This symptomatic support contributes to easing the overall symptom load and may assist with maintaining functional stability. The medication is also relevant in clinical settings that involve acute or unstable symptom patterns, such as when groups of symptoms appear suddenly or fluctuate rapidly.

“The medication is commonly used to help with symptomatic relief in conditions characterized by periods of heightened symptoms.”

Quick Fact

Quick Fact: Supports Symptom Management for Physical Discomfort in conditions involving recurrent or episodic manifestations.

This assistance is relevant when symptoms intensify and supportive relief is needed, providing support that helps ease the overall symptom burden.

Eligibility and Restrictions for Use

Who Can and Cannot Use Indax?

Indax is approved for use in adult patients (18 years and older) who meet the specified clinical criteria for the medicine's approved indication. Final eligibility is strictly defined by governmental regulatory documents, focusing on patient characteristics and pre-existing medical conditions.

Who Should Not Take Indax (Contraindications)

Indax is contraindicated in patients with a documented history of serious hypersensitivity to the active ingredient or any of its components. Use is also formally prohibited in patients with specific, high-risk pre-existing conditions, which may include a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Certain other severe clinical states, such as severe hepatic or renal impairment or pregnancy, may also be listed as contraindications.

Use in Specific Populations

Population Group Eligibility Status Specific Restriction/Consideration
Pediatric Patients (Under 18) Not Recommended Safety and effectiveness have not been established.
Pregnancy Contraindicated Use is prohibited due to potential fetal risks.
Severe Renal/Hepatic Impairment Contraindicated Use is not allowed in cases of advanced disease.
Older Adults Use with Caution Increased monitoring for adverse reactions, especially those related to renal and cardiovascular function, may be required.

The overall eligibility profile is narrow and is focused on excluding individuals whose clinical state or background significantly increases the inherent risks of the medicine. Its use is therefore limited to an adult population free of specific endocrine cancers, severe organ dysfunction, and hypersensitivity to the drug.

What should I know about interactions with other medicines?

Indax Interactions with other medicines and products

Indax is associated with a highly significant interaction profile that requires careful management and adherence to strict dietary and medication restrictions. The primary mechanism of interaction involves the inhibition of key enzymes (Monoamine Oxidase A and B) responsible for the breakdown of certain chemicals in the body, which can lead to dangerously elevated concentrations.

Contraindicated and High-Risk Combinations

Serotonin Syndrome Risk: Combinations that increase central nervous system serotonin are strictly contraindicated and may lead to a potentially fatal condition known as Serotonin Syndrome. These include, but are not limited to, other antidepressants (such as SSRIs, SNRIs, and most TCAs), certain pain medicines (e.g., tramadol, meperidine), and the herbal supplement St. John’s wort. A mandatory washout period of at least 14 days is required when switching between Indax and these contraindicated serotonergic agents.

Hypertensive Crisis Risk: Co-administration with certain medicinal products and foods containing high levels of tyramine or other pressor amines can cause a sudden, severe increase in blood pressure (Hypertensive Crisis). Products to avoid include specific decongestants (containing phenylephrine or pseudoephedrine) and stimulant drugs. Tyramine-rich foods, such as aged cheeses, cured meats, fermented soy products, and draft beers, must be strictly avoided during therapy and for two weeks after stopping Indax.

Mechanism
Pharmacodynamic (Serotonin Syndrome)
Pharmacodynamic (Hypertensive Crisis)
Pharmacokinetic (CYP enzyme interactions)

All patients must inform healthcare providers and pharmacists that they are taking Indax before starting any new prescription, over-the-counter medication, or herbal product.

Mechanism of Action

How Indax Works

The action of Indapamide (Indax) is defined by a dual-action mechanism that modulates both the renal fluid-handling pathway and vascular resistance. This mechanism results in a coordinated modulation of systemic pressure dynamics.

Modulating Salt and Fluid Balance in the Kidney

Indapamide exerts its influence by selectively inhibiting the Sodium-Chloride Cotransporter (NCC) located in the distal convoluted tubules of the kidney. This molecular blockade prevents the reabsorption of sodium ( Na^+) and chloride ( Cl^-) ions, triggering a cascade where salt and water are retained in the urine and subsequently excreted. The resulting reduction in plasma and extracellular fluid volume is a core physiological adjustment that reduces the circulatory volume load.

Direct Modulation of Vascular Resistance

Separate from its renal action, Indapamide directly engages mechanisms within the arterial walls. The molecule decreases the influx of calcium ions ( Ca^2+) into vascular smooth muscle cells, which is the primary molecular signal for contraction. This reduction in intracellular Ca^2+ causes the vascular muscle to relax, leading to the widening of arteries (vasodilation) and a reduction in Total Peripheral Resistance (TPR). This relaxation modulates systemic vascular resistance.

Complementary Action and Functional Constraints

The drug's overall effect stems from the synergistic interaction between the mechanism of volume reduction and the mechanism of decreased vascular resistance. However, as a functional consequence of the kidney mechanism, inhibiting NCC leads to a compensatory increase in the downstream excretion of potassium ( K^+), which is an inherent constraint of the salt transport mechanism.

Dosage and Administration Information

How to Use Indax

The usage of Indax, which contains the active ingredient Indapamide, follows established parameters for the long-term management of essential hypertension. The medicine is intended for oral administration as a tablet, generally available in 1.25 mg and 2.5 mg strengths.

The administration schedule involves taking the medicine once daily, typically in the morning. The tablet is to be swallowed whole with water and may be taken irrespective of food intake. For essential hypertension, the standard starting dose is 1.25 mg once daily. If the blood pressure response is insufficient, the dosage may be adjusted up to 2.5 mg daily.

Dose adjustments, when necessary, involve an interval of at least four weeks between changes to evaluate the therapeutic effect. If a dose is missed, the practice is to take the next dose at the usual time; a double dose is not taken to compensate.

Usage constraints apply to certain patient groups. Use is not established for pediatric patients (under 18 years of age). Furthermore, there are limits on administration in cases of organ dysfunction, as the use of Indax is contraindicated in severe renal or hepatic failure.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Core Mechanism and Efficacy Studies

Research has evaluated the compound as a treatment option that has been evaluated in research for inflammatory and pain conditions. Studies have been conducted to examine its anti-inflammatory properties, specifically in the context of treating chronic inflammatory joint diseases.

Studies evaluated the compound's effect on the COX-2 enzyme pathway. Research has investigated whether the compound is associated with a reduction in moderate-to-severe pain.

Comparative and Long-term Research

Studies have compared outcomes against traditional NSAIDs, focusing on both therapeutic effect and gastrointestinal tolerability. Trials have evaluated outcomes related to pain and inflammation, including the duration of assessment.

Long-term studies (up to 12 months) have focused on characterizing the safety profile and investigating potential cardiovascular outcomes.

Combination Therapy Research

Research has also explored the use of the compound alongside a standard disease-modifying anti-rheumatic drug (DMARD) in patients with rheumatoid arthritis.

Research findings include:

  • Joint Function: Research has evaluated joint mobility and overall physical function scores, including comparisons to DMARD monotherapy.
  • Patient-Reported Outcomes: Studies have tracked patient-reported measures, such as pain intensity (using a Visual Analogue Scale, or VAS) and quality of life scores.

Safety and Tolerability Profile

The safety profile has been the subject of research in adult populations. Clinical trials have evaluated use for durations up to 14 days.

Research has explored potential risks for individuals with pre-existing heart conditions, and safety monitoring continues. Further studies continue to investigate the drug's use in pediatric populations and in patients with hepatic impairment.

Key Studies & References Randomized controlled trials comparing cyclooxygenase-2 selective inhibitors with nonselective nonsteroidal anti-inflammatory drugs on gastrointestinal and cardiovascular outcomes: a systematic review and meta-analysis

How should Indax be stored and disposed of?

Indax (Indacaterol) capsules must be stored in the original blister packaging to protect them from moisture and must only be removed immediately before use. Do not store the capsules inside the inhaler. Keep the medication in a closed container at room temperature, away from excess heat, moisture, and direct light. It is essential to keep all medicine out of the sight and reach of children.

Never use Indax or any medication beyond the expiry date. For disposal, do not flush unused or expired capsules down the toilet or pour them into a drain unless specifically advised by official guidelines. The safest disposal method for unused or no longer needed medicine is through a medicine take-back program. Consult your healthcare professional or pharmacist regarding proper disposal options available in your area. The inhaler device that comes with the capsules should typically be disposed of once all the capsules in that pack have been used.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagTaiwan

Equivalent of Indax found in:

A-Z Index: